Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $7.73 in the prior trading day, EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) closed at $8.05, up 4.14%. In other words, the price has increased by $4.14 from its previous closing price. On the day, 0.52 million shares were traded. EYPT stock price reached its highest trading level at $8.16 during the session, while it also had its lowest trading level at $7.77.
Ratios:
Our goal is to gain a better understanding of EYPT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.45 and its Current Ratio is at 5.50. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on January 07, 2025, initiated with a Buy rating and assigned the stock a target price of $33.
On August 28, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $15.Jefferies initiated its Buy rating on August 28, 2024, with a $15 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 23 ’24 when ANTHONY P. ADAMIS bought 67,100 shares for $10.04 per share.
David R. Guyer bought 36,975 shares of EYPT for $329,817 on Oct 14 ’24. On Aug 20 ’24, another insider, DICICCO WENDY F, who serves as the Director of the company, bought 2,567 shares for $7.79 each. As a result, the insider paid 19,997 and bolstered with 9,967 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EYPT now has a Market Capitalization of 549420544 and an Enterprise Value of 296897472. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.02 while its Price-to-Book (P/B) ratio in mrq is 1.97. Its current Enterprise Value per Revenue stands at 6.495 whereas that against EBITDA is -2.591.
Stock Price History:
The Beta on a monthly basis for EYPT is 1.52, which has changed by -0.730662 over the last 52 weeks, in comparison to a change of 0.21794415 over the same period for the S&P500. Over the past 52 weeks, EYPT has reached a high of $30.99, while it has fallen to a 52-week low of $6.90. The 50-Day Moving Average of the stock is -1.41%, while the 200-Day Moving Average is calculated to be -18.73%.
Shares Statistics:
The stock has traded on average 913.62K shares per day over the past 3-months and 611110 shares per day over the last 10 days, according to various share statistics. A total of 68.25M shares are outstanding, with a floating share count of 61.83M. Insiders hold about 9.41% of the company’s shares, while institutions hold 82.28% stake in the company. Shares short for EYPT as of 1736899200 were 10581127 with a Short Ratio of 11.58, compared to 1734048000 on 9412339. Therefore, it implies a Short% of Shares Outstanding of 10581127 and a Short% of Float of 17.52.
